Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2018, Vol. 45 Issue (6): 871-874    DOI: 10.12891/ceog4275.2018
Original Research Previous articles | Next articles
The correlation of maternal serum and cord blood copeptin levels with intrapartum fetal distress
İ. Ulu1, *(), Y. Çekmez1, M.S. Gülşen1, E. T. Haberal1, E.E. Yoğurtçuoğlu1, S.B. Tü ürkmen1, B. Sunar2, G. Kıran1
1 Department of Obstetrics and Gynecology, Medical Sciences University İstanbul Ümraniye Medical and Research Hospital, Istanbul, Turkey
2 Department of Biochemistry, Fatih Sultan Mehmet Medical and Research Hospital, Istanbul, Turkey
Download:  PDF
Export:  BibTeX | EndNote (RIS)      
Abstract  
Aim: Fetal distress (FD) is mostly an important sign of fetal hypoxia. The hypothalamic-pituitary-adrenal axis is an important limb of acute stress response. Copeptin is a hormone of endogenous stress. The authors aimed to investigate whether the level of copeptin correlates with FD or not. Material and Methods: Twenty-four pregnant women and their babies with the diagnosis of FD confirmed by category III fetal heart rate (FHR) pattern were compared with 20 uncomplicated pregnant women and their babies who were delivered by elective cesarean section. Results: The mean maternal serum copeptin level showed no significant difference between the mothers of control group and the mothers of FD group (p > 0.05). The mean umbilical cord serum copeptin level showed no significant difference between the groups (p > 0.05). Conclusion: The authors revealed that copeptin is not correlated with the presence of FD, thus further studies are needed to discover new biomarkers.
Key words:  Biomarker      Copeptin      Fetal distress      Vasopressin     
Published:  10 December 2018     
*Corresponding Author(s):  İ. ULU     E-mail:  dripekulu@gmail.com

Cite this article: 

İ. Ulu, Y. Çekmez, M.S. Gülşen, E. T. Haberal, E.E. Yoğurtçuoğlu, S.B. Tüürkmen, B. Sunar, G. Kıran. The correlation of maternal serum and cord blood copeptin levels with intrapartum fetal distress. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(6): 871-874.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog4275.2018     OR     https://ceog.imrpress.com/EN/Y2018/V45/I6/871

[1] H.J. Wang, T.H. Chou, Y.C. Lee, H.K. Au. Acute fatty liver during pregnancy and gestational diabetes insipidus: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 438-441.
[2] R. Suvannasarn, T. Tongsong, P. Jatavan. Amniotic fluid embolism: the pathophysiology, diagnostic clue, and blood biomarkers indicator for disease prediction[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(2): 159-165.
[3] R. Einikytė, A. Dapkeviciute, V. Dzenkeviciute, S. Kasnauskiene, V. Sapoka, D. Ramasauskaite. The importance of angiogenic and antiangiogenic biomarkers in pathogenesis and early diagnosis of preeclampsia[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(4): 485-492.
[4] Tatsuya Ishiguro, Takao Ishiguro. Abnormal bending of the umbilical cord due to adhesion of the cord to the placenta[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 787-788.
No Suggested Reading articles found!